121 related articles for article (PubMed ID: 8870694)
21. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.
Omokaro SO; Desierto MJ; Eckhaus MA; Ellison FM; Chen J; Young NS
J Immunol; 2009 Mar; 182(6):3414-22. PubMed ID: 19265119
[TBL] [Abstract][Full Text] [Related]
22. Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway.
Ashany D; Song X; Lacy E; Nikolic-Zugic J; Friedman SM; Elkon KB
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11225-9. PubMed ID: 7479970
[TBL] [Abstract][Full Text] [Related]
23. Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells.
Ju ST; Cui H; Panka DJ; Ettinger R; Marshak-Rothstein A
Proc Natl Acad Sci U S A; 1994 May; 91(10):4185-9. PubMed ID: 7514297
[TBL] [Abstract][Full Text] [Related]
24. Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice.
Yui MA; Brissette WH; Brennan DC; Wuthrich RP; Rubin-Kelley VE
Am J Pathol; 1991 Aug; 139(2):255-61. PubMed ID: 1867317
[TBL] [Abstract][Full Text] [Related]
25. IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway.
Schwarting A; Moore K; Wada T; Tesch G; Yoon HJ; Kelley VR
J Immunol; 1998 Apr; 160(8):4074-81. PubMed ID: 9558118
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
Cancer Immunol Immunother; 1998 Nov; 47(3):143-8. PubMed ID: 9829839
[TBL] [Abstract][Full Text] [Related]
27. Enhanced response of macrophages to CSF-1 in autoimmune mice: a gene transfer strategy.
Moore KJ; Naito T; Martin C; Kelley VR
J Immunol; 1996 Jul; 157(1):433-40. PubMed ID: 8683149
[TBL] [Abstract][Full Text] [Related]
28. Vasculitis-susceptible genes in mice with a deficit in Fas-mediated apoptosis.
Nose M; Terada M; Nishihara M; Kamogawa J; Miyazaki T; Mori S; Nishimura M; Wang Y; Kamoto T; Hiai H
Int J Cardiol; 1998 Oct; 66 Suppl 1():S37-41; discussion S43. PubMed ID: 9951801
[TBL] [Abstract][Full Text] [Related]
29. TNF-alpha enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease.
Moore KJ; Yeh K; Naito T; Kelley VR
J Immunol; 1996 Jul; 157(1):427-32. PubMed ID: 8683148
[TBL] [Abstract][Full Text] [Related]
30. The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity.
Conceição-Silva F; Hahne M; Schröter M; Louis J; Tschopp J
Eur J Immunol; 1998 Jan; 28(1):237-45. PubMed ID: 9485203
[TBL] [Abstract][Full Text] [Related]
31. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
Shimizu M; Fontana A; Takeda Y; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jan; 207(1):41-8. PubMed ID: 11161452
[TBL] [Abstract][Full Text] [Related]
32. Fas system-mediated apoptosis suppresses lymphopoiesis.
Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice.
Kobata T; Takasaki K; Asahara H; Hong NM; Masuko-Hongo K; Kato T; Hirose S; Shirai T; Kayagaki N; Yagita H; Okumura K; Nishioka K
Immunology; 1997 Oct; 92(2):206-13. PubMed ID: 9415028
[TBL] [Abstract][Full Text] [Related]
34. Aberrant expression and dysfunction of Fas antigen in MRL/MpJ-lpr/lpr murine ovary.
Xu JP; Li X; Mori E; Guo MW; Mori T
Zygote; 1998 Nov; 6(4):359-67. PubMed ID: 9921647
[TBL] [Abstract][Full Text] [Related]
35. Nephritogenic cytokines and disease in MRL-Fas(lpr) kidneys are dependent on multiple T-cell subsets.
Wada T; Schwarting A; Chesnutt MS; Wofsy D; Rubin Kelley V
Kidney Int; 2001 Feb; 59(2):565-78. PubMed ID: 11168938
[TBL] [Abstract][Full Text] [Related]
36. A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid.
Qu WM; Miyazaki T; Terada M; Okada K; Mori S; Kanno H; Nose M
Clin Exp Immunol; 2002 Jul; 129(1):27-34. PubMed ID: 12100019
[TBL] [Abstract][Full Text] [Related]
37. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage.
Yoshida R; Sanchez-Bueno A; Yamamoto N; Einaga-Naito K
J Immunol; 1997 Jul; 159(1):15-21. PubMed ID: 9200433
[TBL] [Abstract][Full Text] [Related]
38. CD95 (Fas) may control the expansion of activated T cells after elimination of bacteria in murine listeriosis.
Fuse Y; Nishimura H; Maeda K; Yoshikai Y
Infect Immun; 1997 May; 65(5):1883-91. PubMed ID: 9125576
[TBL] [Abstract][Full Text] [Related]
39. Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease.
Bobé P; Bonardelle D; Reynès M; Godeau F; Mahiou J; Joulin V; Kiger N
J Immunol; 1997 Nov; 159(9):4197-204. PubMed ID: 9379013
[TBL] [Abstract][Full Text] [Related]
40. Mac-1 and Fas activities are concurrently required for execution of smooth muscle cell death by M-CSF-stimulated macrophages.
Vasudevan SS; Lopes NH; Seshiah PN; Wang T; Marsh CB; Kereiakes DJ; Dong C; Goldschmidt-Clermont PJ
Cardiovasc Res; 2003 Sep; 59(3):723-33. PubMed ID: 14499874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
